Published in the journal Lancet Psychiatry, researchers recruited 82 participants motivated to quit marijuana but had struggled on their own in the past. Subjects, all diagnosed with cannabis use disorder, were then given three varying amounts of medical-grade CBD or a placebo in the first stage of the trial. Researchers discovered 200mg of CBD was ineffective and so only administered 400mg and 800mg doses in the second trial.


This post was originally published on this site